NMYC is a well-known oncogene found to be expressed in neuroblastomas and retinoblastomas and also in myeloid and lymphoid leukemias [35], but it has not previously been reported to be dysregulated in CML. The gene discussed is MYCN; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.